Table 3 : Prevalence of cancer in female RLS cases and non cases
according to age group and study.
| DHS | SHIP-1 | COR- Study |
Cancer registry1 | |||
| Age group | RLS+ | RLS- | RLS+ | RLS- | RLS+ | -- |
| <34 years, % | 0 | 0 | 11.1 | 0* | 0 | 0.2 |
| 35-44 years, % | 6.7 | 3.1 | 2.7 | 2.4 | 5.8 | 0.8* |
| 45-54 years, % | 8.3 | 2.1 | 0 | 4.1 | 11.0 | 2.1* |
| 55-64 years, % | 15.0 | 8.5 | 8.6 | 3.3* | 4.0 | 3.8* |
| 65-74 years, % | 11.1 | 8.8 | 7.1 | 6.4 | 11.8 | 5.1* |
| 75+ years, % | -- | -- | 12.5 | 11.6 | 13.1 | 6.1* |
| TOTAL, % | 9.9 | 4.7 | 6.5 | 4.1 | 12.1 | 2.1* |
| OR, unadjusted (95% CI) |
2.24 (0.94-5.32) | 1.63 (0.91-2.92) | 6.61 (5.76-7.59) | |||
| OR, age adjusted (95% CI) |
1.93 (0.80-4.65) | 1.34 (0.74-2.42) | 2.97 (2.59-3.40) | |||
| Restricted to age group 25-74 years: | ||||||
| TOTAL, % | 9.9 | 4.7 | 5.8 | 3.3 | 11.9 | 1.6* |
| OR, unadjusted (95% CI) |
2.24 (0.94-5.32) | 1.80 (0.93-3.46) | 8.33 (7.14-9.72) | |||
| OR, age adjusted (95% CI) |
1.93 (0.80-4.65) | 1.47 (0.76-2.86) | 3.17 (2.72-3.69) | |||
* p<0.05 for the comparison within the age stratum (Chi Square Test)
¹RLS prevalence in the source population (n=1,344,175) unknown